Cover Image
市場調查報告書

Ensol Biosciences Inc.- 產品平台分析

Ensol Biosciences Inc. - Product Pipeline Review - 2016

出版商 Global Markets Direct 商品編碼 354955
出版日期 內容資訊 英文 30 Pages
訂單完成後即時交付
價格
Back to Top
Ensol Biosciences Inc.- 產品平台分析 Ensol Biosciences Inc. - Product Pipeline Review - 2016
出版日期: 2016年02月24日 內容資訊: 英文 30 Pages
簡介

Ensol Biosciences Inc.是總公司設立於韓國的生物科技企業,正在進行基於生物資訊學技術的生醫材料之藥物研發及開發。同時也在研究開發退化性疾病的治療藥,及抗癌劑,抗生劑等生技藥品,及in-silico分析,整合基因測序及分析,新藥物標的發現,抗生劑的新標的發現等。

本報告提供Ensol Biosciences Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Ensol Biosciences Inc.的基本資料

  • Ensol Biosciences Inc.概要
  • 主要資訊
  • 企業資料

Ensol Biosciences Inc.:R&D概要

  • 主要的治療範圍

Ensol Biosciences Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 開發中產品-轉出授權產品
    • 轉出授權產品/聯合治療模式

Ensol Biosciences Inc.:開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發階段的產品/聯合治療模式

Ensol Biosciences Inc.:藥物簡介

  • Charis-1000
  • Hesed-1000
  • Peniel-5000
  • Amos-1000
  • Ephphatha-1000
  • Hesed-2000
  • Hesed-3000
  • Hesed-4000
  • Hesed-5000
  • Moriah-1000
  • Shiloah-1000

Ensol Biosciences Inc.:開發平台分析

  • 各分子類型

Ensol Biosciences Inc.:最近的開發平台資訊

Ensol Biosciences Inc.:暫停開發中的計劃

Ensol Biosciences Inc.:總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

目錄
Product Code: GMDHC07955CDB

Summary

Global Markets Direct's, 'Ensol Biosciences Inc. - Product Pipeline Review - 2016', provides an overview of the Ensol Biosciences Inc.'s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Ensol Biosciences Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Ensol Biosciences Inc.
  • The report provides overview of Ensol Biosciences Inc. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Ensol Biosciences Inc.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Ensol Biosciences Inc.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

  • Evaluate Ensol Biosciences Inc.'s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Ensol Biosciences Inc.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Ensol Biosciences Inc.'s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Ensol Biosciences Inc. Snapshot
    • Ensol Biosciences Inc. Overview
    • Key Information
    • Key Facts
  • Ensol Biosciences Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Ensol Biosciences Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Out-Licensed Products
      • Out-Licensed Products/Combination Treatment Modalities
  • Ensol Biosciences Inc. - Pipeline Products Glance
    • Ensol Biosciences Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Ensol Biosciences Inc. - Drug Profiles
    • Charis-1000
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Hesed-1000
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Peniel-5000
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Amos-1000
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Ephphatha-1000
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Hesed-2000
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Hesed-3000
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Hesed-4000
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Hesed-5000
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Moriah-1000
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Shiloah-1000
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Ensol Biosciences Inc. - Pipeline Analysis
  • Ensol Biosciences Inc. - Pipeline Products by Molecule Type
  • Ensol Biosciences Inc. - Recent Pipeline Updates
  • Ensol Biosciences Inc. - Dormant Projects
  • Ensol Biosciences Inc. - Locations and Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Ensol Biosciences Inc., Key Information
  • Ensol Biosciences Inc., Key Facts
  • Ensol Biosciences Inc. - Pipeline by Indication, 2016
  • Ensol Biosciences Inc. - Pipeline by Stage of Development, 2016
  • Ensol Biosciences Inc. - Monotherapy Products in Pipeline, 2016
  • Ensol Biosciences Inc. - Out-Licensed Products in Pipeline, 2016
  • Ensol Biosciences Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2016
  • Ensol Biosciences Inc. - Preclinical, 2016
  • Ensol Biosciences Inc. - Discovery, 2016
  • Ensol Biosciences Inc. - Pipeline by Molecule Type, 2016
  • Ensol Biosciences Inc. - Recent Pipeline Updates, 2016
  • Ensol Biosciences Inc. - Dormant Developmental Projects,2016

List of Figures

  • Ensol Biosciences Inc. - Pipeline by Top 10 Indication, 2016
  • Ensol Biosciences Inc. - Pipeline by Stage of Development, 2016
  • Ensol Biosciences Inc. - Monotherapy Products in Pipeline, 2016
  • Ensol Biosciences Inc. - Out-Licensed Products in Pipeline, 2016
  • Ensol Biosciences Inc. - Pipeline by Molecule Type, 2016
Back to Top